Results

1–7 of 7 results for Fluocinolone acetonide implant

Fluocinolone Intravitreal Implant in Patients With Macular Edema Due to Retinal Vein Occlusion
Ashkan M. Abbey, MD, FASRS, FAAO
On Demand Cases, Courses, and Papers
2021
Diabetic Retinopathy Progression in Anti-VEGF Versus Fluocinolone Acetonide Implant Treated Eyes Who Are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Annual Meeting Talks
2020
Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis following an Injectable Fluocinolone Acetonide Insert
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2020
Diabetic Retinopathy Progression in Anti-VEGF versus Fluocinolone Acetonide Implant Treated Eyes Who are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Updates from the Field
2020
Progression of diabetic retinopathy in patients treated with 0.2 μg/day
Raymond Iezzi, MD, MS
Updates from the Field
2017
Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017
2-for-1: Removal of 2 Dislocated Fluocinolone Acetonide Implants With Placement of a New Implant
Glenn C. Yiu, MD, PhD
Innovative Retina Surgical Video Series
2013